chr17-31318487-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_014210.4(EVI2A):āc.527A>Gā(p.Gln176Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00477 in 1,614,056 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_014210.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVI2A | NM_014210.4 | c.527A>G | p.Gln176Arg | missense_variant | 2/2 | ENST00000462804.3 | NP_055025.2 | |
NF1 | NM_001042492.3 | c.4836-7333T>C | intron_variant | ENST00000358273.9 | NP_001035957.1 | |||
EVI2A | NM_001003927.3 | c.596A>G | p.Gln199Arg | missense_variant | 3/3 | NP_001003927.1 | ||
NF1 | NM_000267.3 | c.4773-7333T>C | intron_variant | NP_000258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVI2A | ENST00000462804.3 | c.527A>G | p.Gln176Arg | missense_variant | 2/2 | 1 | NM_014210.4 | ENSP00000420557.3 | ||
ENSG00000265118 | ENST00000578584.5 | c.299A>G | p.Gln100Arg | missense_variant | 1/3 | 2 | ENSP00000463981.2 | |||
NF1 | ENST00000358273.9 | c.4836-7333T>C | intron_variant | 1 | NM_001042492.3 | ENSP00000351015.4 |
Frequencies
GnomAD3 genomes AF: 0.00247 AC: 376AN: 152228Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00246 AC: 618AN: 250880Hom.: 2 AF XY: 0.00244 AC XY: 331AN XY: 135598
GnomAD4 exome AF: 0.00501 AC: 7324AN: 1461710Hom.: 20 Cov.: 31 AF XY: 0.00487 AC XY: 3538AN XY: 727152
GnomAD4 genome AF: 0.00247 AC: 376AN: 152346Hom.: 1 Cov.: 32 AF XY: 0.00216 AC XY: 161AN XY: 74506
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | EVI2A: BP4, BS2; NF1: BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Sep 14, 2016 | - - |
See cases Benign:1
Benign, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Apr 01, 2019 | This variant was classified as: Benign. The following ACMG criteria were applied in classifying this variant: BS1,BS2. - |
EVI2A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 11, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at